The same study also found that increased expression of MRPS18B improved the migratory ability of prostate cancer cells through the induction of EMT, via chemokine signalling (CXCL12-CXCR4), and increased EMT transcription factor (TWIST2) expression [29]. This evidence concerns the gene MRPS18B and Familial prostate cancer.